14.936 articles found

Identification and characterisation of the interaction between LRRK2 and DVL proteins

Sancho RMM.

· 2009-01-01

Synucleins and their roles in the pathology of Parkinson's disease as metal binding proteins

Wang X.

· 2009-01-01

A clinical and molecular genetic study into familial and sporadic Parkinson’s Disease

Lewthwaite AJ.

· 2009-01-01

Structural findings in the basal ganglia in genetically determined and idiopathic Parkinson's disease.

Reetz K, Gaser C, Klein C, Hagenah J, Büchel C, Gottschalk S, Pramstaller PP, Siebner HR, Binkofski F.

Mov Disord · 2009-01-01

DOI: 10.1002/mds.22333PMID: 18823048

Pathogenic mutations shift the equilibria of alpha-synuclein single molecules towards structured conformers.

Brucale M, Sandal M, Di Maio S, Rampioni A, Tessari I, Tosatto L, Bisaglia M, Bubacco L, Samorì B.

Chembiochem · 2009-01-01

DOI: 10.1002/cbic.200800581PMID: 19067456

Alpha-synuclein gene rearrangements in dominantly inherited parkinsonism: frequency, phenotype, and mechanisms.

Ibáñez P, Lesage S, Janin S, Lohmann E, Durif F, Destée A, Bonnet AM, Brefel-Courbon C, Heath S, Zelenika D, Agid Y, Dürr A, Brice A, French Parkinson's Disease Genetics Study Group.

Arch Neurol · 2009-01-01

DOI: 10.1001/archneurol.2008.555PMID: 19139307

Clustering of alpha-synuclein on supported lipid bilayers: role of anionic lipid, protein, and divalent ion concentration.

Pandey AP, Haque F, Rochet JC, Hovis JS.

Biophys J · 2009-01-01

DOI: 10.1016/j.bpj.2008.10.011PMID: 19167303

Synchronous vs asynchronous chain motion in alpha-synuclein contact dynamics.

Urie KG, Angulo D, Lee JC, Kozak JJ, Gray HB, Winkler JR.

J Phys Chem B · 2009-01-01

DOI: 10.1021/jp806727ePMID: 19099437

Genetic determinants of hair color and Parkinson's disease risk.

Gao X, Simon KC, Han J, Schwarzschild MA, Ascherio A.

Ann Neurol · 2009-01-01

DOI: 10.1002/ana.21535PMID: 19194882

[The role of apolipoprotein E in patients with amyotrophic lateral sclerosis (a clinical and genetic study)].

Kutakova EV, Zakharova MN, Illarioshkin SN, Kliushnikov SA, Zavalishin IA, Ivanova-Smolenskaia IA.

Zh Nevrol Psikhiatr Im S S Korsakova · 2009-01-01

PMID: 19365373

[Pathogenetic and therapeutic aspects of dementia in Parkinson's disease].

Damulin IV.

Zh Nevrol Psikhiatr Im S S Korsakova · 2009-01-01

PMID: 19385124

Accelerated proteasomal activity induced by Pb2+, Ga3+, or Cu2+ exposure does not induce degradation of alpha-synuclein.

Grunberg-Etkovitz N, Lev N, Ickowicz D, Avital A, Offen D, Malik Z.

J Environ Pathol Toxicol Oncol · 2009-01-01

DOI: 10.1615/jenvironpatholtoxicoloncol.v28.i1.20PMID: 19392651